- Sosei Heptares solves structure of the agonist bound orexin OX2 receptor and identifies small molecule binding site using unique StaR® technology and structure-based approach
- New improved insights into the receptor's structure will help optimize the discovery and development of novel molecules targeting neurological diseases
PR Newswire
TOKYO and LONDON, May 7, 2020